drugset / Trial / NCT04992962

Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee

NCT04992962 ↗

Phase 2 Unknown 66 enrolled Pure Green
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy of PG-OA-10CN and PG-OA-5TH tablets as a better pain reliever in patients with moderate to severe chronic pain due to osteoarthritis of the knee than a placebo.

Timeline

Start
2021-07-29
Primary completion
2021-10-30
Completion
2021-11-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown 10 mg Other
Subject CBN Unknown 10 mg Other
Subject THC Unknown 5 mg Other

Indications